Achieve Life Sciences, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Achieve Life Sciences, Inc. (ACHV) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $0 as of 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2020-03-13
- 2019-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2018-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2018-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2017-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-13 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-01 |
| 2017-09-30 | $3.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $114.00K 10-Q · filed 2017-07-31 |
| 2017-03-31 | $180.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $232.00K 10-Q · filed 2017-07-31 |
| 2016-09-30 | $350.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $971.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $438.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $1.10M 10-K · filed 2017-02-23 |
| 2015-09-30 | $2.84M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $2.97M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $2.54M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $3.00M 10-K · filed 2016-03-09 |
| 2014-09-30 | $3.98M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $320.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $935.00K 10-Q · filed 2014-04-30 |
| 2013-12-31 | $214.00K 10-K · filed 2015-03-26 |
| 2013-09-30 | $548.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $1.09M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $1.99M 10-Q · filed 2013-05-02 |
| 2012-12-31 | $3.42M 10-K · filed 2014-03-11 |
| 2012-09-30 | $5.36M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $7.67M 10-Q · filed 2012-08-02 |
| 2011-12-31 | $7.88M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |